ORDINANCE NO. 071348

 

Amending Chapter 34, Code of Ordinances, by amending Sections 34-53, Report of certain diseases and events required, 34-54, Report of certain conditions required, and 34-56, Persons required to report diseases and conditions, and enacting in lieu thereof new sections of like numbers and subject matters, updating the list of reportable diseases and events.

 

BE IT ORDAINED BY THE COUNCIL OF KANSAS CITY:

 

Section 1. That Chapter 34, Code of Ordinances of the City of Kansas City, Missouri, is hereby amended by repealing Section 34-53, Report of certain diseases and events required, 34-54, Report of certain conditions required, and 34-56, Persons required to report diseases and conditions, and enacting in lieu thereof new sections of like numbers and subject matters, to read as follows:

Sec. 34-53. Report of certain diseases and events required.

(a) Upon laboratory or clinical confirmation the following diseases must be reported to the director: Acquired immunodeficiency syndrome (AIDS), animal bites, arboviral disease (neuroinvasive and non-neuroinvasive disease including West Nile virus (WNV), Western Equine encephalitis (WEE), Saint Louis encephalitis (SLE) and Venezuelan Equine encephalitis (VEE)), bacterial meningitis, campylobacter infections, CD4+ T cell count, chancroid, Chlamydia trachomatis genital infections, Creutzfeldt-Jacob disease, cryptosporidiosis, Cyclospora infection, Dengue fever, diphtheria, ehrlichiosis, Escherichia coli 0157:H7 (and other shiga-toxin producing E.coli (STEC) and shiga-toxin positive, unknown organism), food poisoning (suspected or confirmed; infectious or toxic), giardia, gonorrhea (all manifestations including ophthalmia and pelvic inflammatory disease), Haemophilus influenzae (invasive disease), Hansens disease (leprosy), hantavirus pulmonary syndrome, Hemolytic uremic syndrome (post diarrheal), hepatitis A, hepatitis B acute and chronic (including surface antigen positive pregnant women), hepatitis C acute and chronic, hepatitis D, hepatitis E, human immunodeficiency virus (HIV asymptomatic or symptomatic, reactive HIV antibody or antigen test followed by a positive confirmatory test, detection of HIV nuclei acid (RNA or DNA), HIV viral culture, other testing that indicates HIV infection, and viral load measurement including non-detectable results), human immunodeficiency virus (HIV)-exposed newborn infant (i.e., newborn infant whose mother is infected with HIV), human immunodeficiency virus (HIV) test results (including both positive and negative results) for children less than two (2) years of age whose mothers are infected with HIV, influenza (including novel influenza A virus infections and influenza-associated pediatric deaths), legionellosis, leptospirosis, listeriosis, Lyme disease, malaria, measles, meningococcal disease (invasive), mumps, mycobacterial infections (including active tuberculosis disease (both pulmonary and extrapulmonary), latent tuberculosis infection (LTBI), mycobacterial disease other than tuberculosis (MOTT), and positive Mantoux skin tests), outbreaks (including nosocomial) or epidemics of any illness, disease or condition that may be of public health concern, pertussis, poliomyelitis (paralytic), poliovirus infection (nonparalytic), psittacosis, rabies, rabies post-exposure prophylaxis (initiated), Rocky Mountain spotted fever, rubella (including congenital syndrome), salmonellosis (including typhoid fever), shigellosis, streptococcal Group A invasive disease, Streptococcus pneumoniae drug resistant disease or invasive disease in children less than five (5) years of age, syphilis (all stages including congenital syndrome), tetanus, toxic shock syndrome (staphylococcal or streptococcal), trichinosis, vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-resistant Staphylococcus aureus (VRSA), varicella infection (deaths or outbreaks only), vibriosis, Yellow fever, yersinia, and any others declared reportable by the director of health

(b) Upon suspicion of, or confirmation, the following diseases must be reported to the director: adult respiratory distress syndrome (ARDS) in patients under 50 years of age (without a contributing medical history), anthrax, botulism, brucellosis, cholera, encephalitis (arthropod-borne), food poisoning (infectious or toxic) with multiple cases or resulting in hospitalization, glanders, plague, Q fever, rabies (human), ricin toxin, Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV), smallpox or adverse reaction to smallpox vaccination, staphylococcal enterotoxin B, T-2 mycotoxins, tuberculosis disease, tularemia, viral hemorrhagic fevers, and others declared reportable by the director of health; and the occurrence of epidemics or outbreaks of any illness or disease which may be of public health concern.

(c) Incidence of absenteeism of 20% greater than the daily norm in any public or private school must be reported to the director; the director shall provide assistance to schools in the calculation of baseline absenteeism rates and reporting thresholds.

 

(d) Unless otherwise specified, the report shall include the name, time and date of diagnosis, date of birth, sex, race, address or location, telephone number, name of the attending physician, name of the disease, condition or finding diagnosed or suspected, date of onset, all associated treatment for the reportable condition, name and address of treating facility (if any), any appropriate laboratory results and other such facts and information which may be available. For diseases listed in (a) the report shall be made and received by the director of health within two days of diagnosis in writing or by telephone, facsimile communication or other rapid communication. For diseases listed in (b) and (c) the report shall be made and received by the director within four hours of suspicion or confirmation by telephone, facsimile communication or other rapid communication.

Sec. 34-54 Report of certain conditions required.

(a) The following disease conditions must be reported to the director: arsenic poisoning, acute chemical poisoning, carbon monoxide poisoning, hyperthermia, hypothermia, any blood lead level regardless of age, methemoglobinemia, occupational lung diseases, heavy metal poisoning, pesticide poisoning, and respiratory diseases triggered by environmental factors (including environmentally or occupationally induced asthma and bronchitis).

(b) Unless otherwise specified, the report notification shall include the name, date of diagnosis, date of birth, sex, race, address or location, telephone number, name of the physician, disease, condition or finding diagnosed or suspected, date of onset, name and address of treating facility (if any), any appropriate laboratory results and other such facts and information that may be available. The report shall be made to the director within seven days of diagnosis in writing or by telephone, facsimile communication or other rapid communication.

Sec. 34-56. Persons required to report diseases and conditions.

(a) The following persons are required to file with the director of health the reports required in sections 34-53, 34-53.1 and 34-54:

(1) Duly licensed physicians;

(2) Physicians assistants;

(3) Advanced practice nurses;

(4) Every nurse, superintendent, or principal of a public or private school;

(5) Every owner or any person in charge of a child care facility;

(6) Administrator of each institution. The reports filed by such administrator shall not be considered the divulging of confidential information, and does not relieve the responsible physician or other person of the duty to report the same case.

(b) Any person in charge of a plasma center or blood donating center shall report when blood extracted from a person tests positive for the human immunodeficiency virus or hepatitis viruses by prevailing laboratory techniques.

(c) Any person in charge of a clinical laboratory shall report when a laboratory examination of any specimen derived from the human body yields microscopical, cultural, chemical, immunological, serological, or other evidence suggestive of those communicable diseases or disease conditions deemed reportable. This reporting requirement also applies to laboratory specimens sent to another laboratory for analysis or evaluation. Isolates of the following specimens must be submitted to the Missouri Department of Health Laboratory for epidemiological or confirmation purposes:

(1) anthrax

(2) cholera

(3) diphtheria

(4) Escherichia coli 0157:H7

(5) Haemophilus influenzae from invasive disease

(6) Influenza virus-associated pediatric mortality

 

(7) Listeria

(8) malaria (plasmodium species)

(9) measles (rubeola)

(10) Mycobacterium tuberculosis

(11) Neisseria meningitides, invasive disease

 

(12) Orthopoxvirus (smallpox, cowpox-vaccinia, monkeypox)

(13) Other Shiga Toxin positive organisms

 

(14) pertussis (Bordetella pertussis)

 

(15) plague (Yersinia pestis)

(16) salmonella, all species

 

(17) Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

(18) shigella, all species

(19) Staphylococcus aureus, vancomycin intermediate and resistant strains (VISA and VRSA)

 

(20) Tularemia, pneumonic

Submission of specimens does not relieve the person in charge of a clinical laboratory from the reporting requirement.

(d) It shall be unlawful for any person to fail to make a report required in this article within the applicable reporting time.

 

_____________________________________________

 

Approved as to form and legality:

 

 

___________________________________

Joseph Guarino

Assistant City Attorney